HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFRA’s New Prez On Fragrance Transparency, The Science/Society ‘Interface’

This article was originally published in The Rose Sheet

Executive Summary

Four months into her presidency, the International Fragrance Association’s new head discusses key issues and priorities, including ingredient disclosure in a sector that jealously guards its trade secrets.

You may also be interested in...



EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling

EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.

Target Paints Bullseye On Preservatives, Fragrance Secrets With 2020 Goals

Mega-retailer Target announces plans to achieve full ingredient transparency and eliminate “unwanted” but much-used preservatives and other chemicals from beauty and personal-care products on its shelves by 2020. The new strategy is “ambitious,” it says, but Target plans to invest up to $5m to support green chemistry innovation, working closely with supply-chain partners to find solutions.

EU Industry Guidance Supports Essential Oil Eco-Assessment

While no “definitive methodology” for assessing environmental risks associated with essential oils and other natural complex substances, the new guidance should help steer producers and cosmetic manufacturers in their efforts to compile and assess data for compliance with the EU’s REACH and CLP regs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108622

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel